Alerts will be sent to your verified email
Verify Email
SANJIVIN
|
Sanjivani Paranteral
|
Aayush Wellness
|
Gennex Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Quarterly Sales Volume - Injectables
|
n/a | n/a | n/a |
|
Quarterly Sales Volume - Orals
|
n/a | n/a | n/a |
|
Quarterly Sales Volume - Nutraceuticals
|
n/a | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
-37.68 % | -4.78 % | 7.82 % |
|
5yr average Equity Multiplier
|
-1.69 | 3.4 | 1.53 |
|
5yr Average Asset Turnover Ratio
|
1.39 | 2.08 | 0.75 |
|
5yr Avg Net Profit Margin
|
7.02 % | 15.89 % | 7.88 % |
|
Price to Book
|
7.47 | 34.17 | 1.61 |
|
P/E
|
34.95 | 66.28 | 17.89 |
|
5yr Avg Cash Conversion Cycle
|
-55.03 Days | 406.01 Days | 43.23 Days |
|
Inventory Days
|
28.68 Days | 56.86 Days | 49.12 Days |
|
Days Receivable
|
21.4 Days | 406.01 Days | 50.53 Days |
|
Days Payable
|
284.6 Days | 90.96 Days | 75.36 Days |
|
5yr Average Interest Coverage Ratio
|
15.99 | 394.43 | 6.21 |
|
5yr Avg ROCE
|
-87.74 % | 4.61 % | 11.17 % |
|
5yr Avg Operating Profit Margin
|
9.71 % | 8.22 % | 10.47 % |
|
5 yr average Debt to Equity
|
-0.72 | 0.63 | 0.18 |
|
5yr CAGR Net Profit
|
n/a | -1.67 % | 43.63 % |
|
5yr Average Return on Assets
|
11.72 % | -2.49 % | 5.16 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
28.87 % | 0.0 | 19.83 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 21.79 % |
|
Change in Promoter Holding (3 Yrs)
|
1.52 % | -32.52 % | -2.22 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sanjivani Paranteral
|
Aayush Wellness
|
Gennex Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|